University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Robert Powers Publications

Published Research - Department of Chemistry

April 2001

Solution Structure of B. subtilis Acyl Carrier Protein
Guang-Yi Xu
Department of Biological Chemistry, Wyeth Research, Cambridge, MA 02140, USA

Amy Tam
Department of Biological Chemistry, Wyeth Research, Cambridge, MA 02140, USA

Laura Lin
Department of Biological Chemistry, Wyeth Research, Cambridge, MA 02140, USA

Jeffrey Hixon
Millennium Pharmaceuticals, Inc., Cambridge, MA

Christian C. Fritz
Millennium Pharmaceuticals, Inc., Cambridge, MA
See next page for additional authors

Follow this and additional works at: https://digitalcommons.unl.edu/chemistrypowers
Part of the Chemistry Commons

Xu, Guang-Yi; Tam, Amy; Lin, Laura; Hixon, Jeffrey; Fritz, Christian C.; and Powers, Robert, "Solution
Structure of B. subtilis Acyl Carrier Protein" (2001). Robert Powers Publications. 8.
https://digitalcommons.unl.edu/chemistrypowers/8

This Article is brought to you for free and open access by the Published Research - Department of Chemistry at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Robert Powers Publications
by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Authors
Guang-Yi Xu, Amy Tam, Laura Lin, Jeffrey Hixon, Christian C. Fritz, and Robert Powers

This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
chemistrypowers/8

Published in Structure 9:4 (April 2001), pp. 277–287. Copyright © 2001 Elsevier Science Ltd. Used by permission.
http://www.sciencedirect.com/science/journal/09692126
Submitted November 2000; revised January 2001; accepted February 2, 2001.

Solution Structure of B. subtilis Acyl Carrier Protein
Guang-Yi Xu*, Amy Tam*, Laura Lin*,
Jeffrey Hixon†, Christian C. Fritz†, and
Robert Powers*‡

Introduction
The biosynthesis of fatty acids consists of a series of reactions that are catalyzed by specific enzymes [1]. The organization of the enzymatic activity is significantly different
between eukaryotic cells and prokaryotic and plant cells. In
eukaryotic cells, large multifunctional enzymes exist with
distinct domains that are associated with a particular function. Conversely, in prokaryotic and plant cells, the various
enzymatic activities are associated with individual proteins
that are loosely associated with each other. Acyl carrier protein (ACP) is a discrete, small acidic protein (9 kDa) in prokaryotic and plant cells that plays an essential role in fatty
acid biosynthesis, whereas, in animal tissue, ACP is a subunit of the fatty acid synthetase (FAS). ACP is the carrier of
fatty acids during fatty acid biosynthesis and is responsible
for acyl group activation [1, 2 and 3].
A unique feature of ACP is the presence of the 4’phosphopantetheine (4’-PP) prosthetic group. The 4’-PP moiety
is attached through a phosphodiester linkage to a specific
conserved serine residue found in all ACPs. ACP exists in
both an active (holo) and inactive (apo) form in which activation of ACP is mediated by holo-acyl carrier protein synthase (ACPS). ACPS transfers the 4’-PP moiety from coenzyme A to Ser36 of apo-ACP to produce holo-ACP and 3’,
5’-ADP in a Mg+2-dependent reaction. During biosynthesis
of a long-chain fatty acid, the fatty acid chain is attached to
ACP via a thioester linkage to the terminal cysteamine thiol
of the 4’-PP prosthetic group, where it is then elongated by
the FAS system. A potential function of the 4’-PP prosthetic
group is to act as a tether that serves to transfer the growing fatty acid chains between the various enzymes or active sites in the FAS system [4].
ACP is a central component of and plays a fundamental role in fatty acid and other biosynthetic pathways that require acyl transfer steps [5, 6, 7, 8 and 9]. The activation of
ACP by ACPS is critical to this function in which both ACP
and ACPS were identified as being essential for the viability of E. coli [10 and 11]. Furthermore, both ACP and ACPS
are viable targets for a drug discovery program, since the
enzymes are essentially unique to prokaryotic cells. This
is made further evident by previous efforts to determine
the structures for E. coli ACP and act apo-ACP prior to the
structure determination of B. subtilis ACP reported herein
[12, 13, 14 and 15]. Since the activation of ACP is mediated
by its interaction with ACPS, interfering with either the activity of ACPS or the binding interaction of ACPS with ACP
may prove to be a valuable approach for developing novel
antibiotics. Toward this goal, we present the NMR resonance assignments and the determination of the solution
conformation of B. subtilis ACP.
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Summary
Background: Acyl carrier protein (ACP) is a fundamental
component of fatty acid biosynthesis in which the fatty acid
chain is elongated by the fatty acid synthetase system while
attached to the 4’-phosphopantetheine prosthetic group (4’PP) of ACP. Activation of ACP is mediated by holo-acyl carrier protein synthase (ACPS) when ACPS transfers the 4’-PP
moiety from coenzyme A (CoA) to Ser36 of apo-ACP. Both
ACP and ACPS have been identified as essential for E. coli
viability and potential targets for development of antibiotics.
Results: The solution structure of B. subtilis ACP (9 kDa) has
been determined using two-dimensional and three-dimensional heteronuclear NMR spectroscopy. A total of 22 structures were calculated by means of hybrid distance geometrysimulated annealing using a total of 1050 experimental NMR
restraints. The atomic rmsd about the mean coordinate positions for the 22 structures is 0.45 ± 0.08 Å for the backbone
atoms and 0.93 ± 0.07 Å for all atoms. The overall ACP structure consists of a four α-helical bundle in which 4’-PP is attached to the conserved Ser36 that is located in a helix II.
Conclusions: Structural data were collected for both the
apo and holo forms of ACP that suggest that the two forms
of ACP are essentially identical. Comparison of the published
structures for E. coli ACP and actinorhodin polyketide synthase acyl carrier protein (act apo-ACP) from Streptomyces
coelicolor A3(2) with B. subtilis ACP indicates similar secondary structure elements but an extremely large rmsd between
the three ACP structures (>4.3 Å). The structural difference
between B. subtilis ACP and both E. coli and act apo-ACP is
not attributed to an inherent difference in the proteins, but is
probably a result of a limitation in the methodology available
for the analysis for E. coli and act apo-ACP. Comparison of
the structure of free ACP with the bound form of ACP in the
ACP-ACPS complex reveals a displacement of helix II in the
vicinity of Ser36. The induced perturbation of ACP by ACPS
positions Ser36 proximal to coenzyme A and aligns the dipole of helix II to initiate transfer of 4’-PP to ACP.
Keywords: ACP, ACPS, fatty acids biosynthesis, NMR, solution structure
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fined, as evident by the atomic rmsd of the 22 simulated
annealing structures about the mean coordinate positions
where the backbone and all atoms’ rmsd are 0.45 ± 0.08 Å
and 0.93 ± 0.07 Å, respectively. For residues that are only
in secondary structure regions, the backbone and all atoms’ rmsd are 0.35 ± 0.08 Å and 0.85 ± 0.06 Å, respectively. The B. subtilis ACP NMR structure is consistent with
a high-quality structure based on PROCHECK and Ramachandran analysis [18 and 19]. A Ramachandran plot of
the average-minimized structure shows a total of 83.1% of
the residues in the most favored region, 12.7% in the additional allowed region, and 2.8% in the generously allowed
regions, with only 1 residue (Val17) in a disallowed region.
Val17 is a member of the twist turn, which is located in the
long loop between helices I and II. PROCHECK analysis
indicates an overall G factor of -0.23 and only two bad contacts. Table 1 also lists other relevant refinement statistics,
all of which indicate reasonable geometry and energetics
for the final ensemble and average-minimized structures.
Figure 1. Solution Structure of B. subtilis ACP
(a). The best-fit superposition of the Ca traces of the 22 members of
the final ensemble of NMR-derived structures of B. subtilis ACP.
(b) Ribbon diagram of the averaged and minimized NMR structure
of B. subtilis ACP. For (a) and (b), helixes I-VI are colored red, green,
orange, and magenta, respectively. The crossover loops are colored
blue.
(c) Residues that exhibit two distinct sets of 15N/NH chemical shifts
associated with the apo and holo forms of B. subtilis ACP are colored
red, and S36 is colored magenta.
(d) The hydrophobic pocket composed of residues F28, V39, V40,
L42, V43, L46, and V65 (blue) is illustrated. The surface corresponding to S36, which is proximal to the hydrophobic pocket, is colored
magenta

Results and Discussion
Secondary Structure Analysis and Structure
Determination
The regular secondary structure elements of ACP were
identified through a qualitative analysis of sequential and
medium- range NOEs obtained from the 15N/13C-edited
NOESY spectra, NH exchange rates, φ/ψ dihedral torsion
angles from Talos [16], and the 13Cα and 13Cβ secondary
chemical shifts [17]. The secondary structure of B. subtilis
ACP is composed of four helical regions that correspond
to residues A1-R14 (αI), S36-F50 (αII), D56-E60 (αIII), and
G66-Q75 (aVI). Three loop regions of various lengths connect the four helices.
The calculated three-dimensional structure of B. subtilis
ACP is well defined by 1050 distance restraints, 54 hydrogen bond restraints, and 92 torsion angle restraints. The αhelical regions of the calculated structure are similar to the
predicted secondary structure elements. Figure 1a shows
the best-fit superposition of the Ca traces for the final ensemble of 22 structures, illustrating the consistency within
the a helix “framework” and variability of one long (20 residues) and two short interhelix loops (3 and 6 residues). The
ribbon diagram of the ensemble average-minimized structure is shown in Figure 1b. The NMR structure is well de-

Description of the B. subtilis ACP NMR-Derived
Structures
The solution structure of the B. subtilis ACP consists of a
four α-helical bundle where helices I (D2-L15, colored red
in Figures 1a and 1b), II (S36-E49, colored green in Figures 1a and 1b), and IV (V65-Q75, colored magenta in
Figures 1a and 1b) are essentially parallel and have an
approximately equal length (11-14 residues) with an updown-down topology. Helix III (D56-K61, colored orange in
Figures 1a and 1b) is shorter relative to the other helices
and packs effectively perpendicular to the helical bundle.
Three different length loops (colored blue) connect the four
helices. A long loop (G16-D35) connects helix I to helix II. A
shorter loop (F50-S55) connects helix II to III, and a 3-residue loop (I62-T64) links helix III and VI. The a helices I, II,
and IV of B. subtilis ACP have an amphipathic character.
Many of the long-range NOEs involved in packing of the
helical bundle occur between the hydrophobic side chains,
corresponding to residues L4, V7, I11, and L15 in a I; V39,
V40, L42, V43, and L46 in a II; and V65, A68, V69, and I72
in a VI. These residues form the hydrophobic core of ACP,
in which the side chain interactions between these residues
stabilize the global fold of the protein. The B. subtilis ACP
has two phenylalanines, F28 and F50, that are located in
the second half of the first long loop and correspond to the
first residue of the second loop, respectively. In the average-minimized structure, both F28 and F50 interact with
the hydrophobic core that is formed by the packing of the
helical bundle. F28 and F50 are in close contact with residues I10, I11, and L15 in a I; V39, L42, and L46 in a II;
and V65 and I72 in a VI, which is consistent with the experimental long-range NOEs. Conversely, the side chains
of many hydrophilic residues in the helical bundle are solvent exposed. These residues correspond to E5, T8, K9,
and D13 in a I; D38, E41, E45, E47, and D48 in a II; and
D67, N70, Y71, N74, and Q75 in a IV.
Relative to the other helices, α III is highly hydrophilic
and contains only 1 hydrophobic residue, A59. Given
its high rmsd relative to the helix bundle, a III could be
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viewed as part as of the loop region that connects helix II
and IV. In fact, this short helix is missing in the structures
of the other members of the ACP family [12 and 13]. In the
B. subtilis ACP structure, long-range NOEs that are consistent with the ACP three-dimensional structure indicate that
A59 is in close contact with residues V40 in a II and V65
in a VI. This indicates that A59 participates in a hydrophobic interaction with the helical bundle. Additionally, D58 is in
close proximity with Y71 from a VI, where the phenolic hydroxyl might form a hydrogen bond with the carboxyl side
chain from D58. These interactions define the close contact
of helix III with both helices II and VI and determine its perpendicular orientation (~60°).
The long loop between helices I and II is composed of
20 residues (G16-D35) and starts with a distorted short turn
(G16-A20) that is defined by numerous medium-range (i,i+2
and i,i+3) interactions. The remainder of this long loop is not
well defined and effectively adopts an unstructured random
conformation that is a result of a deficiency of medium- and
long-range NOE restraints. The lack of a defined structure
for most of the long loop region is also made apparent by
an absence of slow-exchanging amide protons. As a result,
the rmsd for this loop region is much higher (0.57 Å and
1.25 Å) for backbone and all atoms, respectively, than the
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rmsd for secondary structure regions (0.30 Å and 0.80 Å).
The long loop has an amphipathic characteristic that contains 10 hydrophobic and 10 hydrophilic residues. The B.
subtilis ACP structure indicates that most of the hydrophilic
residues are exposed to the solvent, while most of the hydrophobic residues are orientated toward the central hydrophobic helical core. In addition to the long-range interactions described previously for F28, a number of long-range
NOEs were observed between the hydrophobic side chains
from the long loop region and both the C-terminal end of
helix I and the N-terminal end of helix VI.
Holo and Apo Forms of B. subtilis ACP
The NMR sample used for the B. subtilis ACP structure
determination consists of an approximate 60:40 mixture
of the holo and apo forms, respectively. The 4’-PP moiety from CoA is attached to the conserved S36 on ACP,
as evident by the presence of two distinct sets of chemical shifts in the 1H-15N HSQC spectrum for the N-terminal region of helix II that is in the vicinity of S36 (Figure 2).
Figure 2a illustrates the distinct chemical shifts that are
observed in the 1H-15N HSQC for the residues in the vicinity of the 4’-PP prosthetic group. For example, the am-
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Figure 2. 2-D 1H-15N HSQC and 3-D 15N-edited NOESY-HMQC Spectrum of Apo and Holo Forms of B. subtilis ACP
(a) An expansion of the 2-D 1H-15N HSQC spectrum, illustrating residues that exhibit distinct 15N/NH chemical shifts in the apo and holo forms of
B. subtilis ACP.
(b) Composite of amide strips taken from the 3-D 15N-edited NOESY-HMQC spectrum of B. subtilis ACP, corresponding to residues S36-V40 that
exhibit distinct 15N/NH chemical shifts in the apo and holo forms of B. subtilis ACP. For clarity, some of the crosspeak assignments are labeled.
HDO and cross-peaks that are attributed to other residues are labeled with an asterisk

ide proton and 15N chemical shifts of S36 are at 8.76 ppm
and 112.7 ppm, respectively, for holo-ACP compared to
8.47 ppm and 114.0 ppm for apo-ACP. Similarly, L37 exhibits amide proton and 15N chemical shifts at 7.99 ppm
and 124.4 ppm for holo-ACP, compared to 8.03 ppm and
123.3 ppm for apo-ACP. D38 exhibits amide proton and
15N chemical shifts at 8.34 ppm and 120.0 ppm for holoACP, compared to 8.17 ppm and 119.7 ppm for apo-ACP.
The residues that incur a chemical shift change as a function of the holo and apo forms of ACP are colored in Figure 1c, where S36 is colored magenta, and the other perturbed residues are colored red.
Figure 3. Sequence Alignment of E. coli and act apoACP with B. subtilis ACPIdentical residue types are
colored black, and identical residue classes are colored red

Despite the observed chemical shift perturbations in the
1H-15N HSQC spectra between the holo and apo forms of
ACP, the 13C and 1H side chain chemical shifts for these
residues are essentially unchanged. This was apparent from
the HSQC-based triple-resonance experiments, in which a
doubling of peaks was observed based on the different amide proton and 15N resonances for the apo and holo forms,
but the remainder of the crosspeaks were identical or nearly
identical. Additionally, the 15N-edited NOESY spectra did not
show any distinct NOE patterns for holo- and apo-ACP residues (Figure 2b). This was also the case for S36, which has
the largest chemical shift difference in the 1H-15N HSQC
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spectra. For holo-ACP, no additional NOEs were observed
between the 4’-PP prosthetic group and the protein itself,
except for the linkage between the 4’-PP prosthetic group
and S36. These results suggest that the structures of holoACP and apo-ACP are essentially the same and that the 4’PP prosthetic group of holo-ACP does not incur any preferential interactions with the protein. This implies that either
the 4’-PP prosthetic group is essentially solvent exposed or
experiences rapid exchange between multiple low- affinity
binding interactions with ACP. Because the function of ACP
is to carry the fatty acid chain as it is elongated by FAS, it is
not surprising that the 4’-PP prosthetic group is readily accessible at the protein surface. S36 is located at the top of
helix II at the surface of the protein, making it readily accessible by ACPS and FAS (Figure 1c). Proximal to S36 is a
hydrophobic pocket, composed of residues F28, V39, L42,
V43, L46, and I62, which may be involved in binding the
acyl chain as it is lengthened (Figure 1d).
The addition of acyl moieties to ACP results in stabilizing the protein against pH denaturation. There is a direct
correlation between the degree of protection from pH denaturation and the increasing length of the acyl chain [20
and 21]. Additionally, the binding affinity of acyl-ACP to octyl-sepharose based on the length of the acyl chain and the
lack of affinity for apo-ACP suggests the presence of an
acyl chain binding site on ACP [22]. Furthermore, 1D 19F1H cross-relaxation and chemical shift perturbation experiments have identified a number of potential ACP residues
that may be involved in the interaction of the acyl chain or
a conformational change in ACP that occurs upon acylation [23 and 24]. Again, the extent of the observed chemical
shift changes correlates with an increase in the acyl chain
length. Finally, the X-ray structure of ACP complexed with
ACPS demonstrates that the 4’-PP prosthetic group is embedded in the hydrophobic pocket of ACP [25]. These results, taken in total, support the proposition that the growing
acyl chain that is attached to ACP binds in a hydrophobic
pocket that is proximal to S36. The affinity of the acyl chain
for the hydrophobic pocket increases as a function of increasing chain length. This follows the expected trend that
as the chain length increases and becomes more hydrophobic in nature, there is a greater tendency for the acyl
chain to avoid the solvent. In the case of the NMR structure of B. subtilis ACP reported here, only the 4’-PP prosthetic group is attached to ACP. This differs from the studies reported above, excluding the X-ray structure, in which
the acyl chains contained anywhere from 2 to >10 additional carbon atoms relative to 4’-PP. The 4’-PP prosthetic
group itself is not extensively hydrophobic, and, as evident
from the results described above, increasing the acyl chain
length has a pronounced effect on hydrophobicity. Therefore, it is not too surprising that the NMR structure does not
identify that the 4’-PP binds exclusively into the hydrophobic pocket, and that the apo- and holo-ACP structures are
essentially identical.
Comparison of the B. subtilis ACP Structure with the
E. coli ACP and act apo-ACP Structures
NMR structures for E. coli ACP and act apo-ACP were reported in the literature [12, 13 and 15] prior to initiation of
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our efforts on the structure determination of B. subtilis ACP.
Amino acid sequence alignments indicate that E. coli ACP
is highly homologous to B. subtilis ACP, where 53 of 76 residues correspond to identical residue classes (70%) (Figure 3). Similarly, comparison of act apo-ACP with B. subtilis
ACP indicates that 38 of 76 residues correspond to identical residue classes (50%) (Figure 3). The overall sequence
homology suggests that the three proteins should have a
similar global fold (Figures 4a and 4b).
Comparison of the published structures for E. coli ACP
(PDB ID:1ACP) and act apo-ACP (PDB ID:2AF8) with B.
subtilis ACP indicate that the three proteins have similar
secondary structure elements, where the α-helical content corresponds to 51%, 49%, and 60% for E. coli, act
apo-, and B. subtilis ACP, respectively. The overall ACP
structure consists of a four a-helical bundle where three
a helices are relatively long (6-15 residues) and one helix is short (0-6 residues). Despite the similarity in the
amino acid sequence and secondary structure features,
the global fold for the three ACP structures is distinct. This
is made readily apparent by the superposition of the average-minimized structures for E. coli ACP and act apoACP with B. subtilis ACP (Figures 4a and 4b). The atomic
rmsd of the Ca atoms between E. coli and B. subtilis ACP
for the 53 homologous residues is 4.63 Å. The comparison improves to 3.82 Å for similar secondary structure regions. Similarly, the atomic rmsd of the Ca atoms between
act apo- and B. subtilis ACP for the 38 homologous residues is 4.39 Å. Again, an improvement to 2.66 Å occurs
when only similar secondary structure regions are used in
the comparison. Moreover, the rmsd between the Ca atoms for the 36 identical residue classes between E. coli
and act apo is 5.60 Å, which is much higher than the deviations between these two proteins and B. subtilis ACP.
These large rmsd indicate that the three ACP structures
are relatively unique.
The observed large rmsd between the three ACPS
structures are located mainly in the short a helix III and the
long loop region between helix I and II. The short a helix III
is not present in the average-minimized act apo-ACP structure. Also, in some models, the short a III is absent from the
ensemble of structures for both E. coli and act apo-ACP.
Some of the observed differences between the B. subtilis ACP structure and both the E. coli and act apo-ACP
structures result from unusual features of the E. coli and
act apo-ACP structures. An example is the presence of a
large kink in a helix I for E. coli ACP that results in this helix being extremely distorted. An additional factor contributing to the difference between B. subtilis ACP structure and
both the E. coli and act apo-ACP is attributed to the relative displacement of the helical regions. The observation of
distinct structures for the three ACP proteins is unexpected
given the reasonable sequence homology and the obvious
fact that the proteins are functionally identical. During the
time frame that the three structures for ACP have been determined, there have been advances in NMR methodology
in its application in solving solution structures of protein.
Therefore, a potential source for the structural difference
may have resulted from limitations in the structure determination process for the early ACP structures instead of
an intrinsic difference in the proteins. Furthermore, physi-
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cal behavior encountered with the previous ACP structures
that were not a factor in the B. subtilis ACP structure would
have only exasperated the methodology limitations for the
earlier structures.
The NMR analysis of the E. coli ACP structure suggests the existence of equilibrium between multiple conformers [13 and 14]. Additional technical difficulties were
reported in the structure determination of spinach ACP
and the nodulation protein NodF from Rhizobium leguminosarum, in which both proteins share homology with
ACP [26 and 27]. In both cases, only low-resolution structures were determined, because of the lack of experimental restraints and the fact that three-dimensional structures
were not released to the Protein Data Bank. Nevertheless,
the overall fold and secondary structure of spinach ACP
and the nodulation protein NodF were consistent with the
E. coli ACP structure. These results clearly suggest an inherent technical difficulty that was encountered with the
previous ACP structures that was not a factor in the B.
subtilis ACP structure.
The structure determinations for both E. coli and act
apo-ACP were limited to homonuclear two-dimensional
NMR experiments. In the case of the B. subtilis ACP structure, we were able to take full advantage of the current
state of multidimensional heteronuclear NMR methodologies utilizing 15N/13C isotope-enriched B. subtilis ACP [28].
This approach was not readily accessible for the determination of the E. coli and act apo-ACP structures. Further
complicating the inherent limitations in the analysis of 2-D
NMR data is the helical nature of ACP, causing the NMR
spectra to exhibit relatively narrow chemical shift dispersion. As a result of these relative limitations, the structures
for E. coli and act apo- ACP were based on a minimal number of distance restraints, especially long-range distance
restraints, compared to those used in the determination of
the B. subtilis ACP structure. The E. coli ACP (77 residues)
structure was based on a total of 478 distance restraints
comprising 30 H bond distance restraints; 101 intraresidue
distance restraints; and 205 sequential, 87 short-range,
and 55 long-range interresidue distance restraints. The average number of distance restraints was only 6.2 restraints
per residue. Similarly, the act apo-ACP (86 residues) structure was based on a total of 747 distance restraints comprising 48 H bond distance restraints; 240 intraresidue distance restraints; and 235 sequential, 131 short-range,
and 93 long-range distance restraints. The average number for act apo-ACP was 8.7 restraints per residue. Conversely, the B. subtilis ACP (76 residues) structure reported
herein was based on a total of 1050 distance restraints,
with an average of 13.8 restraints per residue, comprising
54 H bond distance restraints; 337 intraresidue distance
restraints; and 231 sequential, 188 short-range, and 240
long-range interresidue restraints. Similarly, the B. subtilis
ACP structure was based on more φ and ψ dihedral angle
restraints relative to both E. coli and act apo-ACP. A total
of 96 φ and ψ dihedral angle restraints were used for the
B. subtilis ACP structure, compared to 54 and 63 for the E.
coli and act apo-ACP structures, respectively. In addition,
the B. subtilis ACP structure was refined using both Ca/
Cß chemical shift restraints [29] and a conformational data
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base potential [30], which were not available refinement
approaches for the E. coli and act apo-ACP structures.
Clearly, the increase in the number of the restraints for the
B. subtilis ACP structure was attributed to the utilization of
13C/15N-labeled ACP in combination with 3-D heteronuclear
NMR experiments. This approach overcomes most of the
limitations encountered with the unlabeled ACP samples
and 2-D based NMR experiments.
It has been well-established that the accuracy and precision of NMR solution structures is correlated with the
number of structural restraints [31]. In addition to the number of restraints, the quality of the ACP structures is also
reflected by the rmsd between each structure in the ensemble relative to the average structure. Typically, a highresolution NMR structure exhibits a backbone rmsd of <0.5
Å. As apparent in Table 2, the structures for E. coli and act
apo-ACP have extremely high rmsd values, suggestive of a
low-resolution structure, whereas, the B. subtilis ACP structure reported herein demonstrates rmsd values consistent
with a high-quality structure. Again, these differences presumably reflect the inherent limitations of 2-D homonuclear
NMR methodologies compared to multidimensional heteronuclear NMR approaches and the resulting increase in the
number of restraints needed to solve the B. subtilis ACP
structure.
Recently, the solution structure of a peptidyl carrier protein (PCP) was published [32]. PCP has a similar biological
function to ACP and contains a conserved serine where the
cofactor 4’-phosphopantetheine is attached. The sequence
alignment between PCP and ACP indicates a lack of sequence homology, with the exception of the site of cofactor
binding. In addition, the calculated pI values of PCP, E. coli,
and act apo-ACP are strikingly different. However, PCP has
topology and structural features similar to those of ACP,
where the PCP structure is composed of a distorted four αhelical bundle with an extended loop between the first two
helices. The similarity between the PCP and B. subtilis ACP
structures supports the general belief that function is a primary factor in defining a protein’s structure. Therefore, the
observed structural difference between B. subtilis ACP with
both E. coli and act apo-ACP appears to be attributed to
limitations in the available NMR methodology for the E. coli
and act apo-ACP structures, which was further exasperated by the physical behavior of both E. coli and act apoACP. Given the high-sequence homology and the identical
functions, it appears unlikely that the observed differences between the three ACP structures reflect an in-
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Figure 4. Overlays of the Ribbon Diagrams of B. subtilis ACP with the
E. coli, act apo, and X-ray ACP Structures
(a) B. subtilis ACP (red) and E. coli ACP (green).
(b) B. subtilis ACP (red) and act apo-ACP (blue).
(c) Free ACP NMR (red) and X-ray ACP in the ACP-ACPS complex
(turquoise)

herent difference in the structure of these proteins. The
accuracy and precision of the B. subtilis ACP structure
is supported by the high-quality structural and energetic
statistics and the relatively low atomic rms differences
reported in Table 1. Further support for the reliability of
the B. subtilis ACP structure is the fact that the B. subtilis ACP was useful in aiding in the solution of the X-ray
structure of ACP in the B. subtilis ACP-ACPS complex
[25]. Similar attempts to use the E. coli ACP structure to
assist the X-ray structure refinement of the ACP-ACPs
complex was not successful, presumably a result of the
large difference in the E. coli ACP structure.
Comparison of the Structures of Free B. subtilis
ACP with ACP in the ACP-ACPS Complex
An overlay of the ribbon diagrams and Ca traces of the NMR
structure for the free B. subtilis ACP and the X-ray structure
of ACP from the B. subtilis ACP-ACPS complex with bound
CoA [25] is illustrated in Figure 4c. The backbone atomic
rms difference between the free and bound forms of ACP
is 2.11 Å and 1.57 Å for all backbone atoms and regions of
defined secondary structure, respectively. Figure 5b illustrates the Ca deviations on a per residue basis (A1-Q73)
between the free and bound forms of ACP. The observed
Ca deviations range from 0.43 to 4.87 Å, with significant differences localized in the first long loop and the N terminus

Figure 5. Structural Differences Between the Free and Bound Forms
of B. subtilis ACP
(a) The best-fit superposition of the Ca atoms of helix II of free ACP
(blue) and bound ACP (red) in the ACP-ACPS complex. The ribbons
(pink) are part of helices I, II, and IV from ACPS in the ACP-ACPS
complex. Part of the hydrophobic contacts in the ACP-ACPS complex
involve L37 from ACP with I15, M18, F25, and F54 from ACPS. S36
from ACP is displaced and closer to E58 from ACPS in the ACP-ACPS
complex. S36 in the free ACP structure is 3.6 Å further away from E58
of ACPS in the ACP-ACPS complex.
(b) Ca deviation between the free B. subtilis ACP structure and
the ACP structure in the ACP-ACPS complex as a function of residue
number

of helix II. The long loop in the free ACP structure is less
defined and unstructured, a result of the limited number of
medium- and long-range distance restraints. Conversely,
for ACP in the ACP-ACPS complex, a short a helix is observed for residues F28-D31 in this long loop. This is the
first example of a helical conformation within the long loop
region for ACP, suggesting a decrease in flexibility in the
ACP-ACPS complex. Comparison of the three long helices between the free and bound ACP structures indicates
that helix VI is shorter in the ACP-ACPS complex (V65Y71, 7 residues) than in the free form (V65-Q75, 11 residues). The C terminus for ACP in the ACP-ACPS complex
appears to exhibit an increase in flexibility that is suggested
by the shorter helix and the missing electronic densities for
the last 3 residues (N74-Q76).
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The X-ray structure of ACP in the ACP-ACPS complex
[25] indicates that the major interactions between holo-ACP
and ACPS are predominately hydrophilic in nature and occurs between helix I of ACPS and helix II of ACP. A key salt
bridge interaction occurs between the side chain carboxyl
of both D35 and D38 in ACP and the side chain guanido
group of R14 from ACPS. This key salt bridge is in the vicinity of S36 from ACP, which is the location of the attachment of 4’-PP from CoA to ACP by ACPS. Two additional
salt bridges, involving residues E41 from ACP and R21
from ACPS and D48 from ACP and both E22 and R24 from
ACPS, respectively, are present in the ACP-ACPS interface. The ACP-ACPS binding interaction is additionally stabilized by two hydrophobic contacts, in which L37 and M44
from ACP protrude into hydrophobic pockets on ACPS, as
shown in Figure 5a. L37 and M44 from ACP extend into the
ACPS pockets formed by residues M18, F25, F54, and I15
and residues F25, R28, and Q22, respectively. The effect
of these interactions between ACP and ACPS is the relative displacement of helix II between the bound ( Figure
5, red) and free ( Figure 5, blue) forms of ACP, where helix II is forced closer to ACPS in the ACP-ACPS complex.
Moreover, the displacement of the N-terminal end of helix II
probably allows for S36 of ACP to be pulled into the ACPS
active site for the attachment of 4’-PP from CoA. E58 is a
highly conserved residue in ACPS that is involved in coordinating the calcium that is bound to CoA. The side chain
for S36 from ACP is in close contact with the side chain
of E58 from ACPS in the ACP-ACPS complex. The close
proximity of S36 from ACP to E58 from ACPS is probably
required for the transfer of the 4’-PP moiety from CoA to
ACP. Superimposing the free ACP structure on the bound
ACP structure in the ACP-ACPS complex indicated that the
side chain for S36 from free ACP is ~3.6 Å further from the
E58 side chain of ACPS than in the complex. In the ACPACPS complex containing bound CoA, the dipole of helix
II in ACP is pointing toward the pyrophosphate moiety of
CoA, which orients S36 near the ß-phosphate of CoA and
an adjacent water molecule [25]. This orientation of helix
II presumably initiates the transfer of the 4’-PP from CoA
to ACP. This then implies that the reorganization of helix
II from ACP upon complex formation with ACPS is a necessary component of the mechanism to transfer the 4’-PP
moiety from CoA to ACP.
Biological Implications
Acyl carrier protein (ACP) is an essential component in the
biosynthesis of fatty acids and other biosynthetic pathways
that require acyl transfer steps. The function of ACP is to
carry the fatty acid chain as it is elongated by FAS [1, 2 and
3]. ACP is converted to its active holo form by holo-acyl carier protein synthase (ACPS) with the transfer of 4’-phosphopantetheine from coenzyme A to a conserved serine (S36)
on ACP. The extension of the fatty acid chain then occurs
through a linkage to the terminal thiol of 4’-PP attached to
ACP. ACP and ACPS have been demonstrated to be critical
to the viability of E. coli [10 and 11], suggesting that the activities of ACP and ACPS are potential targets for the devel-
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opment of novel antibiotics. A detailed understanding of the
structural contribution of ACP and ACPS to the activity of
both proteins is fundamental to a drug design program.
Comparison of the B. subtilis ACP structure with both
the E. coli and act apo-ACP structures indicates a significant discrepancy between the three ACP structures. Because of the identical function and high-sequence homology between the proteins, we do not believe that there is
an inherent difference in the ACP structures. Instead, the
evidence suggests that the discrepancy is a result of technical difficulties combined with the inherent limitations of
the NMR methodologies available to determine the E. coli
and act apo-ACP structures. This was not an issue in the
structure determination of B. subtillis ACP. The application
of NMR to solve pro-tein structures has continued to evolve
during the time period in which the original ACP structures
were determined [28]. The utilization of the current state of
multidimensional heteronuclear NMR techniques in conjunction with 13C and 15N isotope enrichment permitted the
determination of a high-resolution structure for B. subtilis
ACP, as evident by the structural, energetic, and rmsd statistics (Table 1). We believe that the high-quality B. subtilis ACP structure provides an accurate description of the
structure of ACP.
Comparison of the free ACP structure with the structure
of ACP in the ACP-ACPS complex, and comparison of the
apo-ACP structure with the holo-ACP structure may provide some insight into the mechanism of ACP activation by
ACPS. The addition of 4’-PP to ACP does not result in any
observable difference in the structure of the apo and holo
forms of the protein. Furthermore, there is no evidence for
any interaction between 4’-PP and ACP, except for the attachment at S36. This implies that 4’-PP in ACP is readily accessible by FAS for elongation of the fatty acid chain.
Proximal to S36 is a hydrophobic pocket that may be involved in binding the acyl chain as it is lengthened and becomes more hydrophobic (Figure 1d). The lack of a structural difference between holo- and apo-ACP also suggests
that the dissociation of holo-ACP from the ACP-ACPS complex is not facilitated by a structural change in ACP that is
induced by the attachment of 4’-PP. Nevertheless, ACPS
does induce a significant perturbation in the ACP structure upon complex formation. The result is a displacement
of helix II and the appropriate positioning of S36 from ACP
to enable the transfer of 4’-PP from CoA to ACP. S36 from
ACP is effectively drawn into the ACPS structure into close
proximity to CoA in ACPS, with the alignment of the helix
II dipole with the S36-4’-PP attachment point initiating the
transfer [25]. After transfer of the 4’-PP moiety from ACPS
to ACP occurs, dissociation of the ACP-ACPS complex is
probably facilitated by relaxation of the bound structure of
ACP to its free structure conformation.
Experimental Procedures
B. subtilis ACP Sample Preparation
The uniform 15N/13C-labeled B. subtilis ACP (81 residues) was cloned
into a pGEX-6P-1 vector and expressed in E. coli strain BL21DE3
(pLysS). Cells were grown at 37°C on minimal medium containing
[15N] ammonium sulfate and [U-13C] glucose. For purification, 20 g of
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the above cell pellet was resuspended in 300 ml breaking buffer consisting of 50 mM Tris-Cl (pH 8.0), 300 mM NaCl, 10 mM MgCl2, and
2 mM freshly prepared MnCl2. Protease inhibitor tablets (Boehringer
Mannheim GmbH), RNaseH and DnaseI, (Sigma Chemical Company) were added to the solution to prevent protease activity and to
decrease viscosity of the solution. The cells were lysed by three passages through a microfluidizer and centrifuged at 15,000 × g for 20
min at 4°C to remove the cell debris. Glutathione sepharose 4B resin
(Amersham Pharmacia Biotech) equilibrated with the same breaking buffer was added to the clear supernatent. The mixture was incubated at 4°C for 1 hr prior to packing the resin into a suitable column.
The column was washed, and the GST-ACP was eluted with a buffer
containing 50 mM Tris-Cl (pH 8.0), 10 mM MgCl2, 5 mM DTT, and 60
mM reduced glutathione. The resulting GST-ACP solution was dialyzed overnight against 50 mM Tris-Cl (pH 8.0), 150 mM NaCl, 1 mM
EDTA, and 1 mM DTT. The fusion protein was cleaved with Prescission Protease (Amersham Pharmacia Biotech) at room temperature
for 3 hr at a ratio of 1 U enzyme per 500 μg protein. The resulting
protein mixture was loaded on a MonoQ HR16/10 column (Amersham Pharmacia Biotech), and the ACP protein was eluted with a
NaCl gradient. ACP containing fractions were pooled and loaded on
a TSK G2000 size exclusion column prior to the NMR sample preparation.
NMR Data Collection and Assignments
The NMR sample is a mixture of 15N/13C-double-labeled apo- and
holo-ACP in 50 mM Bis-Tris (pH 6.4), 100 mM NaCl, 10 mM MgCl2,
and 10 mM DTT with 0.02% NaN3 in 5% D2O/95% H2O solution. The
protein concentration was approximately 1 mM.
All spectra were recorded at 25°C on a Varian Unity+ 600 spectrometer equipped with a triple-resonance 1H/13C/15N probe and an
actively shielded z gradient-pulsed field accessories. Two-dimensional
1H-15N HSQC and all HSQC-based 3-D 15N-edited NOESY and 3-D
triple-resonance experiments were recorded with the enhanced-sensitivity-pulsed field gradient approach [33]. This approach provides coherence transfer selection both to improve sensitivity and to eliminate
artifacts as well as for solvent suppression. For the 2-D 1H-15N HSQC
and the 3-D 15N-edited NOESY experiments, hard 13C 180° pulses
were applied in the middle of the t1 period to dephase 13C polarization
during the transfer of magnetization between the proton and the 15N
nuclei. The simultaneous 15N/13C-edited NOESY experiment with separation via the carbon and nitrogen of the destination sites was performed for simultaneous identification of NOEs from both amides and
aliphatic protons [34 and 35].
Data sets were typically processed and displayed on an SGI workstation with the program packages NMRDraw and NMRPipe [36]. A
skewed 60° phase-shifted sine-bell function and a single zero-filling
were used in each dimension prior to Fourier transformation. For triple-resonance 3-D experiments, the time domain was extended by a
factor of two, prior to zero-filling, using froward-backward linear prediction in the 15N (t2) dimension where mirror image linear prediction was
used for constant-time 1H-13C correlation experiments [37]. The programs PIPP and STAPP were used for data analysis and semiautomatic assignments [38].
The complete sequential and side chain assignments (>95%)
of the 1H, 15N, and 13C resonances were based on the following experiments: CBCA(CO)NNH, HNCACB, C(CC)TOCSY_NNH,
H(CC)TOCSY_NNH, and HAHB(CBCACO)NN [33 and 39]. Combination of a 2-D constant time 13C-1H HSQC experiment optimized for
methyls and a 2-D- methyl relay experiment were used for auxiliary
methyl assignments of isoleucine, valine, and leucine, as well as methionine residues. Some ambiguous resonances and sequence assignments were further confirmed by sequential NOEs observed in
the 15N-edited NOESY experiments [40] and simultaneous 15N/13Cedited NOESY experiments [34 and 35]. A table of chemical shifts
has been deposited in the RCSB Protein Data Bank (PDB ID code
1HY8).
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Structure Calculations
The NMR solution structure is based on interproton distance restraints
converted from observed NOEs in both the 15N-edited NOESY [40]
and simultaneous 15N/13C-edited NOESY experiments [34 and 35].
The NOE intensities were classified as either strong (1.8- 2.7 Å), medium (1.8-3.3 Å), or weak (1.8-5.5 Å) restraints. The upper distance
limits for distances involving methyl protons and nonstereospecifically
assigned methylene and methyl protons were corrected appropriately
for center averaging [41], and an additional 0.5 Å was added to the upper distance limits for NOEs involving methyl protons averaging [42
and 43]. φ and ψ torsion angle restraints were obtained from 15N, Ha,
C, and Cß chemical shifts using the TALOS program, in which only
“good” predictions were used to generate a restraint [16].
The ACP polypeptide chain used for the NMR structural analysis
contains 81 residues, including 5 nonnative residues (GPLGS) at the N
terminus. The 5 N-terminal residues were not used in the structure calculation since these residues are essentially unstructured and the proline residue exhibits cis-trans isomerization. The structure of B. subtilis
ACP was determined from a total of 1050 distance restraints comprising 337 intraresidue, 231 sequential, 188 medium, and 240 long- range
distance restraints; 54 hydrogen bond restraints; and 92 torsion angles
constraints comprised of 46 φ and 46 ψ dihedral restraints. The hydrogen bond restraints were based on the observation of slow-exchanging NH protons monitored by 2-D 1H-15N HSQC spectra collected from
5 min to 4 hr after dissolving the protein in a D2O solution.
The structures were calculated using the hybrid distance geometry-dynamical-simulated annealing method of Nilges et al. [44], with
minor modifications [45] using the program XPLOR [46], which is
adapted to incorporate pseudopotential secondary 13Ca/13Cß chemical shift restraints [29] and a conformational database potential [30
and 47]. The target function that is minimized during constrained minimization and simulated annealing comprises only quadratic harmonic
terms for covalent geometry and secondary 13Ca/13Cß chemical shift
restraints, square-well quadratic potentials for the experimental distance and torsion angle restraints, and a quartic van der Waals term
for nonbonded contacts. All peptide bonds were constrained to be planar and trans. There were no hydrogen bonding, electrostatic, or 6-12
Lennard-Jones empirical potential energy terms in the target function.
A family of 36 embedded substructures was generated using distance
geometry, followed by simulated annealing, regularization, and refinement. An iterative procedure was used to successively introduce an increasing number of NOE distance restraints. A final ensemble of 22
structures contained no distance restraint violations greater than 0.2
Å, and no torsion angle restraint violations greater than 2° were obtained.
Structural alignment and atomic rmsd comparison between B. subtilis ACP, E. coli, and act apo-ACP were determined using MolMol [48],
XPLOR [46], and QUANTA (Molecular Simulations).
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restrained minimized mean structure of ACP have been deposited in
the RCSB Protein Data Bank (PDB ID code 1HY8).

